This year, the SOFMEDICA Group celebrates three decades of innovation in the healthcare industry. Founded in 1994, the Group started off with a vision to revolutionize patient care. Today, it stands as a beacon of transformation across six European countries, Romania, Greece, Hungary, Bulgaria, Cyprus, and most recently, Croatia. The Group’s journey is defined not just by the innovative technologies it has introduced in the region, but by the lives it has touched. By focusing on early and precise diagnosis of life-threatening diseases all the way to treating them through the most advanced surgical techniques, the SOFMEDICA Group has consistently strived to prioritize what matters most, the patients.
Since its inception, the SOFMEDICA Group has invested over €55 million in the region. Over the years, the organization has expanded significantly, with an estimated turnover of 70 million euro in 2024. The Group remains steadfast in its mission to empower the industry standards and to support the healthcare professionals by providing them with the tools, training and technology they need to deliver exceptional care, especially in an ever-changing landscape. To date, more than 7 million euro has been invested in developing comprehensive educational programs tailored for healthcare professionals.
The Group has established itself as an industry pioneer by building an entire ecosystem at the service of the healthcare professionals in the region through the deployment of innovative educational programs on the one hand and the development of top-notch medical real estate on the other. This integrated strategy has enabled the Group to achieve several medical firsts in the region, including the introduction of home dialysis, left ventricular assist devices (artificial hearts), robotically assisted surgery, capsule video-endoscopy, and transcatheter valve replacement. These achievements underscore the Group’s commitment to making the most advanced medical solutions accessible to the remotest patients in Europe.
SOFMEDICA Group is convinced that true healthcare transformation occurs where technology, education, and human compassion intersect The Group remains dedicated to empowering healthcare professionals by providing state-of-the-art tools, comprehensive training, and advanced technology essential for delivering exceptional care. To date, over €7 million has been invested in developing extensive educational programs specifically tailored for healthcare professionals. This initiative emphasizes the company’s commitment to advancing industry standards and equipping professionals with the tools and knowledge they need to excel in an evolving landscape.
SOFMEDICA Group’s growth has been sustained through a strategic focus on financial discipline, quality management, and compliance governance. Investing in these areas, although resource-intensive in the short term, has been critical to shaping the company’s culture. What truly sets SOFMEDICA Group apart is its unwavering commitment to compliance, reliability, and long-term partnerships. By embedding a collaborative approach and co-managing risks, the Company provides its corporate clients with a trusted partner focused not just on technology delivery, but also on sustainable outcomes and long-term success.
Looking ahead, SOFMEDICA Group is committed to furthering its legacy by prioritizing digital health innovations, expanding into new regions, and deepening its involvement throughout the patient journey while maintaining an integrated approach to healthcare. The Group intends to enhance patient care by incorporating AI and data-driven technologies into clinical workflows, optimizing operating room efficiencies, and integrating genetic diagnostics into treatment plans. By offering comprehensive solutions that address every stage of patient care—from early diagnosis to recovery—and through strategic partnerships with healthcare systems, SOFMEDICA Group will continue to amplify its impact while upholding the highest standards in modern healthcare delivery.
About SOFMEDICA Group
Our group of healthcare companies has been present in Europe since 1994. With direct operations in Romania, Greece, Hungary, Bulgaria, Croatia & Cyprus, the group aims to build a comprehensive regional ecosystem comprised of five distinct but complementary business lines: SOFMEDICA – Innovative Medical Technology, ISLE ACADEMY – Lifelong Learning & Credentialing for Healthcare Professionals, EMERALD & ASTREA – Personalized Medicine through Genetics & Precise Diagnosis, MEDCITY – Healthcare Real Estate, SOFMEDICA VENTURES – HealthTech Development.
